| Chronic lymphocytic leukemia associated with nephrotic syndrome and dermatomyositis. | |
| | |
MedLine Citation:
|
PMID: 7718972 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Several types of autoimmune complications of chronic lymphocytic leukemia (CLL) have been previously reported. However, the tendency to develop autoantibodies is usually restricted to the hematopoietic system. We report a 68-year-old man who had developed dermatomyositis after ten years of chemotherapy for CLL. He also had secondary nephrotic syndrome at the onset of CLL. Subsequently, the patient died of perforation of the small intestine. The association of both nephrotic syndrome and dermatomyositis with CLL is very rare. We discuss the possibility of a casual relation. |
| | |
Authors:
|
T Ishida; K Aikawa; T Tamura; K Yoshida; C Mikuni; M Fujita; H Isobe; Y Kawakami |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: Internal medicine (Tokyo, Japan) Volume: 34 ISSN: 0918-2918 ISO Abbreviation: Intern. Med. Publication Date: 1995 Jan |
Date Detail:
|
Created Date: 1995-05-23 Completed Date: 1995-05-23 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 9204241 Medline TA: Intern Med Country: JAPAN |
Other Details:
|
Languages: eng Pagination: 15-7 Citation Subset: IM |
Affiliation:
|
Division of Hematology, Sapporo National Hospital. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Autoantibodies / immunology Dermatomyositis / complications*, pathology Fatal Outcome Humans Intestinal Perforation / complications, pathology Leukemia, Lymphocytic, Chronic, B-Cell / complications*, pathology Male Nephrotic Syndrome / complications*, immunology |
| Chemical | |
Reg. No./Substance:
|
0/Autoantibodies |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Recurrent Cushing's disease associated with nephrotic syndrome.
Next Document: Boucher-Neuhauser syndrome associated with hypocalciuric hypercalcemia.